Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Angion Biomedica: Q1 Earnings Insights

Author: Benzinga Insights | May 16, 2022 05:46pm

Angion Biomedica (NASDAQ:ANGN) reported its Q1 earnings results on Monday, May 16, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Angion Biomedica missed estimated earnings by 11.63%, reporting an EPS of $-0.48 versus an estimate of $-0.43.

Revenue was up $1.28 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $1.2 which was followed by a 3.92% increase in the share price the next day.

Here's a look at Angion Biomedica's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.62 -0.72 -0.69 -0.62
EPS Actual 0.58 -0.53 -0.58 -1.56
Revenue Estimate 1.74M 1.06M 470.00K 1.89M
Revenue Actual 25.94M 1.46M 540.00K 371.00K

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Angion Biomedica visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ANGN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist